Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients.

Adv Hematol · 2019 · PMC6935809 · PMID 31929803

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

borderline significancep = 0.054so close (0.05 < p ≤ 0.1)

While patients with higher Gal-3 levels characterized by poor risk ( p = 0.02) than lower Gal.3 lels, also more likely to carry a FLT3-ITD with borderline significance ( p = 0.054).

also in 6,424 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.